Skip to main content
Future Journal of Pharmaceutical Sciences

Table 7 %Recovery of Tezacaftor in human plasma

From: A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products

S. no.

% Level

Conc added (μg/mL)

% Recovery

Average %

S.D

% RSD

1

50%

15

98.2

98.23

0.023

0.05

2

98

3

98.5

4

100%

30

97.93

98.16

0.03

0.05

5

98.36

6

98.2

7

150%

45

96.9

97.6

0.35

0.47

8

96.8

9

99.17

Back to article page